Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aerpio begins Phase IIb of AKB-9778 in diabetic retinopathy

Aerpio Pharmaceuticals Inc. (Cincinnati, Ohio) began the Phase IIb TIME-2b trial to evaluate once- and

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE